Elevated ROR1 expression has been identified as a marker of cancer stemness and EMT in many gynecological malignancies, including fallopian tube epithelial precursor lesions [16], endometrial cancer [46], and epithelial ovarian cancers [26,47]. This evidence concerns the gene ROR1 and ovarian carcinoma.